Mometasone inhalation powder should not be used in children younger than 4 years of age.
Instruct patients to rinse mouth after each use of inhaled mometasone to minimize risk.
Each bottle of mometasone nasal spray should only be used by one person. Clean and dry the affected area. Mometasone nasal spray is in a class of medications called corticosteroids. A very serious allergic reaction to this drug is rare. Glucocorticoids can change the appearance of some lesions and make it difficult to establish an adequate diagnosis and can also delay the healing. Rarely, it is possible that corticosteroids given in the nose will be absorbed into the bloodstream. If you notice other effects not listed above, contact your doctor or pharmacist.
In clinical trials, mometasone furoate shows comparable or significantly better efficacy, depending on the comparator, in all indications studied in both adults and children.
Ask your doctor before use if you are taking the following medications:
The risk of serious psychoses or of major affective illnesses occurring appears to be worse with higher doses.
At least 14 days should elapse between discontinuation of an MAOI intended to treat psychiatric disorders and initiation of therapy with Anafranil.
Report any changes in vision or eye pain to your doctor. It is used to treat nose polyps. Patients should be instructed to rinse their mouth after each administration. Do not give this medication to anyone else, even if they have the same symptoms as you do. Because of the inhibitory effect of corticosteroids on wound healing, patients who have experienced recent nasal septum ulcers, nasal surgery, or nasal trauma should not use a nasal corticosteroid until healing has occurred. When corticosteroids are administered exogenously, increases in blood glucose concentrations would be expected thereby decreasing the hypoglycemic effect of antidiabetic agents.